Advertisement
Screener

Savara Inc (SVRA) Investing Cash Flow

2.2 / 5 stars · 17/39 Roast Me

Savara Inc Investing Cash Flow

Savara Inc (SVRA) reported Investing Cash Flow of $71.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-11

  • Savara Inc net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $32.60M, a 34.00% increase year-over-year.
  • Savara Inc net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $38.78M, a 32.22% increase year-over-year.
  • Savara Inc net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$93.56M, a 622.85% decline year-over-year.
  • Savara Inc net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $21.47M.
  • Savara Inc net cash provided by (used in) investing activities for fiscal 2025 was -$18.44M.
  • Savara Inc net cash provided by (used in) investing activities for fiscal 2024 was -$39.94M.
  • Savara Inc net cash provided by (used in) investing activities for fiscal 2023 was -$57.12M, a 208.49% decline from fiscal 2022.
  • Savara Inc net cash provided by (used in) investing activities for fiscal 2022 was $52.65M.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 monthNet Cash Provided by (Used in) Investing Activities 181 monthNet Cash Provided by (Used in) Investing Activities 184 monthNet Cash Provided by (Used in) Investing Activities 187 monthNet Cash Provided by (Used in) Investing Activities 190 monthNet Cash Provided by (Used in) Investing Activities 193 monthNet Cash Provided by (Used in) Investing Activities 196 monthNet Cash Provided by (Used in) Investing Activities 199 monthNet Cash Provided by (Used in) Investing Activities 202 monthNet Cash Provided by (Used in) Investing Activities 205 monthNet Cash Provided by (Used in) Investing Activities 208 monthNet Cash Provided by (Used in) Investing Activities 211 monthNet Cash Provided by (Used in) Investing Activities 214 month
2026-06-30$32.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
$71.38M
10-Q · filed 2026-08-11
-$22.19M
derived: sum of 3 quarters · filed 2026-08-11
-$721.00K
derived: sum of 4 quarters · filed 2026-08-11
2026-03-31$38.78M
10-Q · filed 2026-05-12
-$54.79M
derived: sum of 2 quarters · filed 2026-05-12
-$33.32M
derived: sum of 3 quarters · filed 2026-05-12
-$8.99M
derived: sum of 4 quarters · filed 2026-08-11
2025-12-31-$93.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
-$72.10M
derived: sum of 2 quarters · filed 2026-03-13
-$47.77M
derived: sum of 3 quarters · filed 2026-08-11
-$18.44M
10-K · filed 2026-03-13
2025-09-30$21.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$45.80M
derived: sum of 2 quarters · filed 2026-08-11
$75.12M
10-Q · filed 2025-11-12
$93.02M
derived: sum of 4 quarters · filed 2026-08-11
2025-06-30$24.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
$53.66M
10-Q · filed 2026-08-11
$71.55M
derived: sum of 3 quarters · filed 2026-08-11
-$26.62M
derived: sum of 4 quarters · filed 2026-08-11
2025-03-31$29.33M
10-Q · filed 2026-05-12
$47.22M
derived: sum of 2 quarters · filed 2026-05-12
-$50.94M
derived: sum of 3 quarters · filed 2026-05-12
-$21.41M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$17.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
-$80.27M
derived: sum of 2 quarters · filed 2026-03-13
-$50.73M
derived: sum of 3 quarters · filed 2026-03-13
-$39.94M
10-K · filed 2026-03-13
2024-09-30-$98.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$68.63M
derived: sum of 2 quarters · filed 2025-11-12
-$57.84M
10-Q · filed 2025-11-12
-$51.27M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$29.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
$40.33M
10-Q · filed 2025-08-13
$46.90M
derived: sum of 3 quarters · filed 2025-08-13
-$9.68M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$10.79M
10-Q · filed 2025-05-13
$17.36M
derived: sum of 2 quarters · filed 2025-05-13
-$39.22M
derived: sum of 3 quarters · filed 2025-05-13
-$40.23M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$6.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
-$50.02M
derived: sum of 2 quarters · filed 2025-03-27
-$51.02M
derived: sum of 3 quarters · filed 2025-03-27
-$57.12M
10-K · filed 2025-03-27
2023-09-30-$56.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$57.59M
derived: sum of 2 quarters · filed 2024-11-12
-$63.69M
10-Q · filed 2024-11-12
-$122.90M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$1.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12
-$7.10M
10-Q · filed 2024-08-12
-$66.31M
derived: sum of 3 quarters · filed 2024-08-12
-$33.32M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31-$6.09M
10-Q · filed 2024-05-09
-$65.31M
derived: sum of 2 quarters · filed 2024-05-09
-$32.31M
derived: sum of 3 quarters · filed 2024-05-09
-$7.12M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$59.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07
-$26.21M
derived: sum of 2 quarters · filed 2024-03-07
-$1.02M
derived: sum of 3 quarters · filed 2024-03-07
$52.65M
10-K · filed 2024-03-07
2022-09-30$33.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$58.19M
derived: sum of 2 quarters · filed 2023-11-09
$111.86M
10-Q · filed 2023-11-09
$110.59M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$25.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$78.86M
10-Q · filed 2023-08-10
$77.59M
derived: sum of 3 quarters · filed 2023-08-10
$90.58M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$53.66M
10-Q · filed 2023-05-15
$52.40M
derived: sum of 2 quarters · filed 2023-05-15
$65.38M
derived: sum of 3 quarters · filed 2023-05-15
$61.95M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$1.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
$11.71M
derived: sum of 2 quarters · filed 2023-03-30
$8.28M
derived: sum of 3 quarters · filed 2023-03-30
-$69.46M
10-K · filed 2023-03-30
2021-09-30$12.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$9.55M
derived: sum of 2 quarters · filed 2022-11-10
-$68.19M
10-Q · filed 2022-11-10
-$68.57M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$3.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
-$81.17M
10-Q · filed 2022-08-11
-$81.55M
derived: sum of 3 quarters · filed 2022-08-11
-$88.41M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$77.74M
10-Q · filed 2022-05-11
-$78.12M
derived: sum of 2 quarters · filed 2022-05-11
-$84.98M
derived: sum of 3 quarters · filed 2022-05-11
-$66.90M
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31-$381.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
-$7.24M
derived: sum of 2 quarters · filed 2022-03-30
$10.84M
derived: sum of 3 quarters · filed 2022-03-30
$9.05M
10-K · filed 2022-03-30
2020-09-30-$6.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$11.22M
derived: sum of 2 quarters · filed 2021-11-12
$9.43M
10-Q · filed 2021-11-12
$26.18M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$18.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$16.30M
10-Q · filed 2021-08-12
$33.05M
derived: sum of 3 quarters · filed 2021-08-12
$39.64M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$1.78M
10-Q · filed 2021-05-13
$14.97M
derived: sum of 2 quarters · filed 2021-05-13
$21.56M
derived: sum of 3 quarters · filed 2021-05-13
$6.63M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$16.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10
$23.34M
derived: sum of 2 quarters · filed 2021-03-10
$8.42M
derived: sum of 3 quarters · filed 2021-03-10
$15.74M
10-K · filed 2021-03-10
2019-09-30$6.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$8.33M
derived: sum of 2 quarters · filed 2020-11-05
-$1.01M
10-Q · filed 2020-11-05
-$142.00K
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30-$14.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$7.60M
10-Q · filed 2020-08-06
-$6.73M
derived: sum of 3 quarters · filed 2020-08-06
-$42.44M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31$7.32M
10-Q · filed 2020-05-07
$8.19M
derived: sum of 2 quarters · filed 2020-05-07
-$27.52M
derived: sum of 3 quarters · filed 2020-05-07
-$15.69M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31$869.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
-$34.84M
derived: sum of 2 quarters · filed 2020-03-12
-$23.01M
derived: sum of 3 quarters · filed 2020-03-12
-$13.62M
10-K · filed 2020-03-12
2018-09-30-$35.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
-$23.88M
derived: sum of 2 quarters · filed 2019-11-07
-$14.49M
10-Q · filed 2019-11-07
-$53.54M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$11.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$21.22M
10-Q · filed 2019-08-08
-$17.83M
derived: sum of 3 quarters · filed 2019-08-08
-$51.27M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$9.39M
10-Q · filed 2019-05-09
-$29.66M
derived: sum of 2 quarters · filed 2019-05-09
-$63.11M
derived: sum of 3 quarters · filed 2019-05-09
2017-12-31-$39.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
-$72.50M
derived: sum of 2 quarters · filed 2019-03-13
-$69.11M
10-K · filed 2019-03-13
2017-09-30-$33.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
-$30.06M
10-Q · filed 2018-11-07
2017-06-30$3.38M
10-Q · filed 2018-08-09
2014-03-31$2.46M
10-Q · filed 2014-05-05
$2.89M
derived: sum of 2 quarters · filed 2014-05-05
-$7.84M
derived: sum of 3 quarters · filed 2014-05-05
-$5.70M
derived: sum of 4 quarters · filed 2014-05-05
-$16.00M
10-Q · filed 2014-05-05
2013-12-31$426.56K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26
-$10.30M
derived: sum of 2 quarters · filed 2014-03-26
-$8.17M
derived: sum of 3 quarters · filed 2014-03-26
-$4.77M
10-K · filed 2014-03-26
-$18.46M
10-K · filed 2014-03-26
2013-09-30-$10.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04
-$8.59M
derived: sum of 2 quarters · filed 2013-11-04
-$5.19M
10-Q · filed 2013-11-04
-$5.45M
derived: sum of 4 quarters · filed 2014-05-05
-$18.88M
10-Q · filed 2013-11-04
2013-06-30$2.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05
$5.54M
10-Q · filed 2013-08-05
$5.28M
derived: sum of 3 quarters · filed 2014-05-05
$4.58M
derived: sum of 4 quarters · filed 2014-05-05
-$8.16M
10-Q · filed 2013-08-05
2013-03-31$3.40M
10-Q · filed 2014-05-05
$3.15M
derived: sum of 2 quarters · filed 2014-05-05
$2.44M
derived: sum of 3 quarters · filed 2014-05-05
$294.46K
derived: sum of 4 quarters · filed 2014-05-05
-$10.29M
10-Q · filed 2013-05-15
2012-12-31-$253.27K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26
-$956.26K
derived: sum of 2 quarters · filed 2014-03-26
-$3.11M
derived: sum of 3 quarters · filed 2014-03-26
-$7.17M
10-K · filed 2014-03-26
-$13.69M
10-K · filed 2013-03-19
2012-09-30-$702.99K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04
-$2.85M
derived: sum of 2 quarters · filed 2013-11-04
-$6.91M
10-Q · filed 2013-11-04
-$8.74M
derived: sum of 4 quarters · filed 2013-11-04
-$13.44M
10-Q · filed 2012-11-05
2012-06-30-$2.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05
-$6.21M
10-Q · filed 2013-08-05
-$8.03M
derived: sum of 3 quarters · filed 2013-08-05
-$13.74M
derived: sum of 4 quarters · filed 2013-08-05
-$12.74M
10-Q · filed 2012-08-06
2012-03-31-$4.06M
10-Q · filed 2013-05-15
-$5.88M
derived: sum of 2 quarters · filed 2013-05-15
-$11.59M
derived: sum of 3 quarters · filed 2013-05-15
-$11.60M
derived: sum of 4 quarters · filed 2013-05-15
-$10.59M
10-Q · filed 2012-05-07
2011-12-31-$1.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-19
-$7.53M
derived: sum of 2 quarters · filed 2013-03-19
-$7.54M
derived: sum of 3 quarters · filed 2013-03-19
-$7.54M
10-K · filed 2013-03-19
-$6.53M
10-K · filed 2012-03-08
2011-09-30-$5.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05
-$5.72M
derived: sum of 2 quarters · filed 2012-11-05
-$5.72M
10-Q · filed 2012-11-05
-$5.74M
derived: sum of 4 quarters · filed 2012-11-05
-$4.70M
10-Q · filed 2011-11-08
2011-06-30-$9.68K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06
-$11.90K
10-Q · filed 2012-08-06
-$30.96K
derived: sum of 3 quarters · filed 2012-08-06
-$29.26K
derived: sum of 4 quarters · filed 2012-08-06
$1.01M
10-Q · filed 2011-08-08
2011-03-31-$2.22K
10-Q · filed 2012-05-07
-$21.28K
derived: sum of 2 quarters · filed 2012-05-07
-$19.58K
derived: sum of 3 quarters · filed 2012-05-07
2010-12-31-$19.05K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-08
-$17.35K
derived: sum of 2 quarters · filed 2012-03-08
-$24.13K
10-K · filed 2012-03-08
2010-09-30$1.70K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
-$5.08K
10-Q · filed 2011-11-08
2010-06-30-$6.78K
10-Q · filed 2011-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Seaport Therapeutics, Inc. (SPTX)United States$1.131B